These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Editorial: The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) - A Fundamental Ally in AD Prevention Research. Porsteinsson AP; Clark ED J Prev Alzheimers Dis; 2020; 7(4):206-207. PubMed ID: 32920620 [No Abstract] [Full Text] [Related]
7. The European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0. Ritchie CW; Muniz-Terrera G; Kivipelto M; Solomon A; Tom B; Molinuevo JL J Prev Alzheimers Dis; 2020; 7(1):8-13. PubMed ID: 32010920 [TBL] [Abstract][Full Text] [Related]
8. Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population. Uspenskaya-Cadoz O; Alamuri C; Wang L; Yang M; Khinda S; Nigmatullina Y; Cao T; Kayal N; O'Keefe M; Rubel C J Prev Alzheimers Dis; 2019; 6(3):185-191. PubMed ID: 31062833 [TBL] [Abstract][Full Text] [Related]
9. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials. Vermunt L; Veal CD; Ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Molinuevo JL; Porteous D; Ritchie K; Scheltens P; Ousset PJ; Ritchie CW; Luscan G; Brookes AJ; Visser PJ Alzheimers Dement; 2018 Jun; 14(6):837-842. PubMed ID: 29604264 [TBL] [Abstract][Full Text] [Related]
10. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings. Vermunt L; Muniz-Terrera G; Ter Meulen L; Veal C; Blennow K; Campbell A; Carrié I; Delrieu J; Fauria K; Huesa Rodríguez G; Ingala S; Jenkins N; Molinuevo JL; Ousset PJ; Porteous D; Prins ND; Solomon A; Tom BD; Zetterberg H; Zwan M; Ritchie CW; Scheltens P; Luscan G; Brookes AJ; Visser PJ; Alzheimers Res Ther; 2020 Jan; 12(1):8. PubMed ID: 31907067 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study. Sato K; Niimi Y; Ihara R; Suzuki K; Toda T; Iwata A; Iwatsubo T J Med Internet Res; 2021 Jul; 23(7):e26284. PubMed ID: 34292159 [TBL] [Abstract][Full Text] [Related]
12. The Alzheimer's Prevention Registry: A Large Internet-Based Participant Recruitment Registry to Accelerate Referrals to Alzheimer's-Focused Studies. Langbaum JB; High N; Nichols J; Kettenhoven C; Reiman EM; Tariot PN J Prev Alzheimers Dis; 2020; 7(4):242-250. PubMed ID: 32920626 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the Open Screening Programs in Recruiting Subjects to Prodromal and Mild Alzheimer's Disease Clinical Trials. Wójcik D; Szczechowiak K; Zboch M; Pikala M J Prev Alzheimers Dis; 2020; 7(4):251-255. PubMed ID: 32920627 [TBL] [Abstract][Full Text] [Related]
14. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials. Grill JD; Zhou Y; Elashoff D; Karlawish J Neurobiol Aging; 2016 Mar; 39():147-53. PubMed ID: 26923411 [TBL] [Abstract][Full Text] [Related]
15. Is Reluctance to Share Alzheimer's Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment? Cox CG; Ryan MM; Gillen DL; Grill JD J Prev Alzheimers Dis; 2021; 8(1):52-58. PubMed ID: 33336225 [TBL] [Abstract][Full Text] [Related]
16. Editorial: Accelerating Preclinical Alzheimer's Clinical Trials through a Trial-Ready Cohort with Diverse Representation. Lee AKW; Correia S; Salloway SP J Prev Alzheimers Dis; 2020; 7(4):204-205. PubMed ID: 32920619 [No Abstract] [Full Text] [Related]
17. Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease. Luo J; Weng H; Morris JC; Xiong C J Prev Alzheimers Dis; 2018; 5(2):110-119. PubMed ID: 29616704 [TBL] [Abstract][Full Text] [Related]
18. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study. Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H; Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152 [TBL] [Abstract][Full Text] [Related]